YMAB — Y-mAbs Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapHigh Flyer

Annual balance sheet for Y-mAbs Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	115	182	106	78.6	67.2
Net Total Accounts Receivable
Net Total Receivables	—	7.71	12.5	22.5	19.7
Total Inventory
Total Other Current Assets
Total Current Assets	122	202	130	111	98.5
Net Property, Plant And Equipment	6.39	5.69	2.34	1.64	0.859
Net Intangible Assets
Other Long Term Assets
Total Assets	132	213	141	128	120
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	19.5	27.9	28.3	20.1	23.7
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	26.2	32.7	32.2	26.9	27.9
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	106	180	109	101	92
Total Liabilities & Shareholders' Equity	132	213	141	128	120
Total Common Shares Outstanding